AMH Levels May Predict Chemotherapy-Related Egg Loss

Cancer chemotherapy can lead to early menopause and sterility. The specific chemo drugs and dose determine the risk of sterility but our ability to accurately predict the affect is limited. AMH is believed to reflect the total number of remaining eggs in the ovaries. This study suggests that AMH levels may provide a better method to study the effect of chemo and also to tract individual fertility potential.

I think more reproductive endocrinologists and oncologists will use this marker for damage to a cancer survivor’s fertility potential. We should have a better grasp on the time-imperative to have a family.

Anti-Mullerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results

This study is from Reproductive BioMedicine Online

Link to Abstract

By | 2010-04-22T20:48:58+00:00 April 19th, 2010|FertilityPreservation, Outcomes|0 Comments

About the Author:

I am a Reproductive Endocrinologist who specializes in Infertility, Ovulation Induction, IUI, Assisted Reproduction (IVF), Donor Eggs, PGD, and Fertility Preservation.

Leave A Comment